Hydroxyzine was originally approved by the FDA in 1957.

Following this, the FDA approved revisions to the safety labeling for hydroxyzine pamoate capsules and oral solution (Vistaril®, made by Pfizer Inc.), advising that their use is contraindicated in patients who have demonstrated prior hypersensitivity to the active moiety or components of the products.

 

Why is this medication prescribed?

Other uses for this medicine

Dosage and using this medicine

What special precautions should I follow?

What should I do if I forget a dose?

What side effects can this medication cause?

What storage conditions are needed for this medicine?

In case of an emergency/overdose